Short-acting insulin market to cross $9b by 2030 | Healthcare Asia Magazine
, APAC
Photo from Envato

Short-acting insulin market to cross $9b by 2030

Key drivers include technological advancements and evolving healthcare policies.

The global market for short-acting insulin is projected to cross $9b by 2030, driven by the rising prevalence of diabetes, said DelveInsight.

The sector’s expansion is also driven by advancements in technology and evolving healthcare policies.

“The development of insulin analogues and improved delivery mechanisms, such as insulin pumps and pens, has enhanced the efficacy and convenience of insulin therapy,” the report said.

In addition, innovations in insulin formulations and delivery systems are expected to expand the range of options available to patients.

Meanwhile, governments and health organisations are focusing on cost control and diabetes management guidelines, which can affect insulin pricing and reimbursement policies. 

Possible changes in reimbursement rates or new regulations for insulin approvals may influence market dynamics and competitive strategies.

“As the landscape evolves, stakeholders will need to navigate a complex environment of innovation, competition, and regulatory changes to effectively meet the needs of patients and healthcare systems,” the report added.

 

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!